TENX

Tenax Therapeutics Stock Analysis

AI Rating

Neutral
  • Quality1/10
  • Growth↑ 5/10
  • Value↓ 4/10
Tenax Therapeutics sales and earnings growth
TENX Growth
Neutral
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↑ 32.69%
  • FCF Y/Y↓ -129.61%
Tenax Therapeutics gross and profit margin trends
TENX Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↑ 2853.56%
Tenax Therapeutics net debt vs free cash flow
TENX Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Tenax Therapeutics stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Biotechnology stocks